Application Information

This drug has been submitted to the FDA under the reference 022537/001.

Names and composition

"LAMIVUDINE, NEVIRAPINE, AND STAVUDINE" is the commercial name of a drug composed of LAMIVUDINE, NEVIRAPINE, AND STAVUDINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022537/001 LAMIVUDINE, NEVIRAPINE, AND STAVUDINE LAMIVUDINE, NEVIRAPINE, AND STAVUDINE TABLET/ ORAL 150MG and 200MG and 30MG
200244/001 LAMIVUDINE, NEVIRAPINE, AND STAVUDINE LAMIVUDINE; NEVIRAPINE; STAVUDINE TABLET/ ORAL 150MG and 200MG and 30MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022537/001 LAMIVUDINE, NEVIRAPINE, AND STAVUDINE LAMIVUDINE, NEVIRAPINE, AND STAVUDINE TABLET/ ORAL 150MG and 200MG and 30MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved